Tumaini Bundibugyo Ebola Vaccine Trial Starts in Bunia
ESTIMATEDDate confidence: ESTIMATEDA target, not a fixed dateHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all ESTIMATED pins69% CONFIDENCEOverall confidence: 69%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins from 50% to 74% confidenceClinicalTrials.gov[1] lists a start date of 2026-10-20 flagged "ESTIMATED" with status "NOT_YET_RECRUITING", and study completion of 2027-06 (estimated).
The Tumaini Phase 2/3 platform trial plans to vaccinate the contacts of confirmed Bundibugyo cases in rings around each case in Bunia, targeting 3,810 participants. Run by the University of Antwerp and INRB with CEPI and WHO, it is registered to start on 20 October 2026.
1.00